Exonate: Exonate closes �1.5 million fundraiser
Exonate, a UK_based early stage biopharma company, has raised �1.5 million pounds to further develop its product line.
Read full article »
Exonate focuses on the discovery and development of treatment for retinal neovascular diseases.
Read more